Navigation Links
Viral Genetics CEO Issues State of the Company Update
Date:2/11/2010

pending patents in her name.

The Competitive Landscape

Our licensed patent rights and licensing agreements give Viral Genetics the exclusive right to develop products based on TPT, TNP and MDT. We believe our lines of research hold tremendous promise for victims of devastating autoimmune diseases such as HIV, AIDS, and Lyme Disease, among others. We also have great hope about our approach to eventually addressing drug resistant cancer cells. Many researchers are now publishing peer-reviewed papers that validate our scientists' initial findings. However, our years of scientific effort and the financial investment it took to get our drug therapies to their current stage of development are solidly protected by exclusively licensed patent rights under and our license agreements.

SAFE HARBOR FOR FORWARD-LOOKING STATEMENTS:

This news release contains forward-looking statements that involve risks and uncertainties associated with financial projections, budgets, milestone timelines, clinical development, regulatory approvals, and other risks described by Viral Genetics, Inc. from time to time in its periodic reports filed with the SEC. None of Viral Genetics' drug compounds are approved by the US Food and Drug Administration or by any comparable regulatory agencies elsewhere in the world. While Viral Genetics believes that the forward-looking statements and underlying assumptions contained therein are reasonable, any of the assumptions could be inaccurate, including, but not limited to, the ability of Viral Genetics to establish the efficacy of any of its drug therapies, including VGV-X, VGV-L, and VGV-S, in the treatment of any disease or health condition, the development of studies and strategies leading to commercialization of those drug compounds in the United States, the obtaining of funding required to carry out the development plan, the completion of stu
'/>"/>

SOURCE Viral Genetics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. CDC Foundation Launches Viral Hepatitis Action Coalition
2. Viral Genetics Files 2009 3rd Quarter Consolidated Financials and Information Statement at Pinksheets.com
3. Peregrine Pharmaceuticals Awarded Second Broad U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
4. Schering-Plough Reports Potent Antiviral Activity With Narlaprevir (SCH 900518), an Investigational, Once-Daily Protease Inhibitor for Hepatitis C
5. Noninvasive Breath Test Predicts Survival in Patients with Viral Hepatitis
6. Trana Discovery and Southern Research Institute Find Bioactive HIV Antiviral Compounds
7. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
8. In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug-Resistant Influenza Viruses
9. Adamas Pharmaceuticals Signs CRADA With U.S. Navy to Conduct Preclinical Studies of Triple-Combination Antiviral Drug Therapy for Influenza A, Including the Novel H1N1 Pandemic Strain
10. ANA773 Demonstrates Significant Antiviral Response in Early Clinical Trial in Hepatitis C Patients
11. Pharmasset Reports Positive Preliminary Antiviral Data With PSI-7851 for the Treatment of Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014  Alere Inc. (NYSE: ALR ... following statement today in support of President Barack ... "As the global leader in rapid diagnostics for infectious ... strategy to address the serious threat of antibiotic resistance. ... Administration on initiatives to promote the development of rapid ...
(Date:9/19/2014)... LONDON , September 19, 2014 ... hat Pharma IQ den äußerst erfolgreichen Serialisierungs-Countdown-Kalender aktualisiert, ... abdeckt. Die interaktive PDF, verfügbar unter pharmaserialisation.com ... an dem sie jeweils in Kraft treten. ... der Serialisierung nicht länger um das "ob", sondern ...
(Date:9/19/2014)... Reductions in kidney failure obtained ... people with diabetes type 2 "Intensive treatment ... the kidneys." Australian researchers have discovered that ... leads to persistent reductions in kidney failure many years ... study has found that, five and a half years ...
Breaking Medicine Technology:Alere Applauds President's Executive Order Combating Antibiotic-Resistant Bacteria 2Pharma IQ stellt weltweite Serialisierungsfristen in seinen Countdown-Kalender 2014 - 2018 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 2ADVANCE-ON Post-trial Observational Study: Blood Pressure Arm and Glucose Arm Results 3
... Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO John ... Watch the Video "Congratulations ... campaign trail to earn the trust and votes of the American ... the state of our economy and jobs. "There ...
... HOPKINTON, Mass., Nov. 3, 2010 ... ), a leading provider of tools and services ... announced a collaboration with Sony DADC Austria AG ... for Caliper,s next generation microfluidics products. The agreement ...
Cached Medicine Technology:PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy 2PhRMA CEO John Castellani Responds to Mid-Term Election, Stresses Importance of Innovation to Help Grow Economy 3Caliper Life Sciences and Sony DADC Collaborate to Develop Plastic Microfluidic Solutions 2
(Date:9/20/2014)... September 21, 2014 Diabetes Protocol ... Pullman that is helping thousands of people learn how ... without shots, pills, or prescriptions has caught the attention ... “There are currently tens of millions of people in ... and Type 2 diabetes, and unfortunately, big pharma makes ...
(Date:9/20/2014)... GA (PRWEB) September 20, 2014 David ... 20, 2014. The first poster looked at the clinical ... cardiac cycle for calculating diastolic function. In conjunction with ... end-stage renal disease and normal LVEF by echo (>50%). ... stress protocol, and standard SPECT. Emory Toolbox 4.0 ...
(Date:9/20/2014)... September 21, 2014 Increases in ... to greater waste treatment volumes. However, government regulations ... waste from landfill. According to IBISWorld industry analyst ... implemented strategies aimed at reducing the volume of ... recycled and recovered.” Still, a large proportion of ...
(Date:9/20/2014)... September 20, 2014 On Monday, September ... $250,000 pediatric cancer research grant from Hyundai Hope on ... University Children’s Hospital located on 11234 Anderson St., in ... Dr. Kimberley Payne, Associate Professor at Loma Linda University ... on leukemia in children. , Loma Linda ...
(Date:9/20/2014)... (PRWEB) September 20, 2014 Lifeinsurancequoteterm.net ... advantages a no medical exam life insurance plan provides ... for vulnerable family members should be a top priority ... for life insurance without taking medical examinations and visiting ... not require medical examinations will provide coverage up to ...
Breaking Medicine News(10 mins):Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 2Health News:Versatility of Emory Toolbox 4.0 Shown at ASNC in Scientific Posters 3Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Waste Treatment and Disposal Services in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 2Health News:Loma Linda University Medical Center Receives $250,000 Research Grant From Hyundai Hope On Wheels In Honor Of National Childhood Cancer Awareness Month 3Health News:No Medical Exam Life Insurance Provides Financial Protection for Families 2
... to see if parents supported the proposal to ban junk ... votes in support//. ,"Ofcom has argued throughout ... advertising would be "disproportionate'," said NHF deputy chief executive Jane ... to the widespread and rising concern about the damage to ...
... pregnancy may be common and those who feel low during ... ,Annette Briley and colleagues from Tommy's Baby Charity here surveyed ... online edition of Daily Mail. ,The survey found ... they felt while being pregnant. Two thirds felt even more ...
... Most expectant parents eagerly wait for the first ultrasound sight of the ... first proof that all is well and the pregnancy is on track. ... of their child until the day of the birth. However this is ... pay hundreds of pounds for a clearer picture of their baby in ...
... the activity of a fat-induced gastrointestinal hormone that promotes ... to researchers at the Texas University Medical Branch at ... Branch at Galveston (UTMB) found the anticancer property of ... and the production of an inflammatory protein that boosts ...
... Administration. has given GlaxoSmithKline PLC's anti-seizure medicine to treat ... ,According to GlaxoSmithKline, the U.K. pharmaceutical company, the ... two and older, as well as adults. ... most-commonly occurring type of generalized seizures, seen in about ...
... Man' clinical trial were given the test drug injections ... monoclonal antibody was TGN 1412 that is supposed to ... have revealed that the victims had been injected 15 ... studies. ,Scientists claim that this 'reckless' mistake ...
Cached Medicine News:Health News:Peek Before Birth 2Health News:Curcumin –New Weapon Against Colorectal Cance 2Health News:Catastrophic Elephant Man Drug Trial Victims Injected Recklessly 2
The Electric H-Base Table is for heavier instruments, or for those who prefer electric elevation. The electric table easily accepts a slit lamp, a single tabletop, or a double tabletop, just as the M...
The Manual Table Base is elevated with an easy to reach elevating wheel for smooth operation. The table base will accept a slit lamp, a single table top, or a double tabletop for more than one instru...
A new, innovative design compliments the proven, 30-year mechanical operating system....
The Encore Stand combines the proven mechanical structure and durability of the popular Deluxe Stand, with a modern, sophisticated appearance....
Medicine Products: